scholarly journals Optimum health and inhibition of cancer progression by microbiome and resveratrol

10.2741/4904 ◽  
2021 ◽  
Vol 26 (3) ◽  
pp. 496-517
Author(s):  
James Stokes III
Keyword(s):  
Cancer Progression

463: Telomerase Inhibition Prevents Androgen Independent Osseous Prostate Cancer Progression

2005 ◽  
Vol 173 (4S) ◽  
pp. 126-127
Author(s):  
Yingming Li ◽  
Melissa Thompson ◽  
Zhu Chen ◽  
Bahaa S. Malaeb ◽  
David Corey ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Prostate Cancer Progression ◽  
Telomerase Inhibition ◽  
Androgen Independent

479: Prostate-Specific Membrane Antigen (PSMA) Expression as a Predictor of Prostate Cancer Progression

2006 ◽  
Vol 175 (4S) ◽  
pp. 155-156
Author(s):  
Matthias D. Hofer ◽  
Sven Perner ◽  
Haojie Li ◽  
Rainer Kuefer ◽  
Richard E. Hautmann ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Prostate Specific Membrane Antigen ◽  
Prostate Cancer Progression ◽  
Specific Membrane ◽  
Psma Expression

951: TOB1 and ID-1 Two Novel Genes Implicated in Bladder Cancer Progression and Prognosis

2004 ◽  
Vol 171 (4S) ◽  
pp. 252-252
Author(s):  
Paul Perrotte ◽  
Nadia Benachenou ◽  
Pierre I. Karakiewicz ◽  
Myriam Senay ◽  
Fred Saad
Keyword(s):  
Bladder Cancer ◽  
Cancer Progression ◽  
Novel Genes

Novel Tool Predicts Prostate Cancer Progression

2007 ◽  
Vol 40 (7) ◽  
pp. 12-13
Author(s):  
FRAN LOWRY
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Prostate Cancer Progression

Secunder prevention of prostate cancer progression with bioactive agents from natural sources to have life quality under control

2010 ◽  
Vol 48 (05) ◽  
Author(s):  
A Blázovics ◽  
P Nyirády ◽  
K Szentmihályi ◽  
G Bekő ◽  
M Sz((udblac)cs ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Life Quality ◽  
Prostate Cancer Progression ◽  
Natural Sources ◽  
Bioactive Agents

Beta haemoglobin (hbb) is a novel marker of breast cancer progression

2014 ◽  
Author(s):  
Mattia Capulli ◽  
Adriano Angelucci ◽  
Anna Teti ◽  
Patrizia Sanita ◽  
Luca Ventura ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Progression ◽  
Breast Cancer Progression

Androgen pathway regulating microRNAs in prostate cancer progression and therapy

2016 ◽  
Author(s):  
Foteini Kalofonou ◽  
Claire Fletcher ◽  
Jonathan Waxman ◽  
Charlotte Bevan
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Prostate Cancer Progression

Oestrogen receptor α promotes prostate cancer progression through dual actions in both epithelia and stroma

2015 ◽  
Author(s):  
Mitchell Lawrence ◽  
Ruth Pidsley ◽  
Stuart Ellem ◽  
Luc Furic ◽  
Shalima Nair ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Oestrogen Receptor ◽  
Prostate Cancer Progression ◽  
Oestrogen Receptor Α

The Variant rs145204276 of GAS5 is Associated with the Development and Prognosis of Gastric Cancer

2018 ◽  
Vol 27 (1) ◽  
pp. 19-24 ◽  
Author(s):  
Qianjun Li ◽  
Gang Ma ◽  
Huimin Guo ◽  
Suhua Sun ◽  
Ying Xu ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Survival Rate ◽  
Cancer Progression ◽  
Regulatory Mechanism ◽  
Tumor Stage ◽  
Kaplan Meier ◽  
Non Coding Rna ◽  
Early Tumor ◽  
Long Non Coding Rna ◽  
Clinicopathological Variables

Background & Aims: Down-regulation of the growth arrest specific transcript 5 (GAS5) (long non-coding RNA) is associated with cell proliferation of gastric cancer (GC) and a poor prognosis. We aimed to investigate whether the variant rs145204276 of GAS5 is associated with the prognosis of GC in the Chinese population, and to unveil the regulatory mechanism underlying the GAS5 expression in GC tissues.Method: 1,253 GC patients and 1,354 healthy controls were included. The frequency of the genotype del/del and the allele del of rs145204276 were compared between the patients and the controls and between different subgroups of patients classified by clinicopathological variables. The overall survival rate was analyzed according to the Kaplan-Meier method using the log-rank test.Results: The frequency of genotype del/del was significantly lower in patients than in the controls (7.0% vs. 9.1%, p = 0.001). Kaplan-Meier analysis showed that genotype del/del was significantly associated with a higher survival rate (p = 0.01). Patients with late tumor stage were found to have a significantly lower rate of genotype del/del than those with an early tumor stage (4.9% vs. 8.8%, p = 0.01). Patients with UICC III and IV were found to have a significantly lower rate of genotype del/del than those with UICC I and II (5.3% vs. 8.1%, p = 0.02).Conclusion: The variant rs145204276 of GAS5 is associated with the development and prognosis of GC. The allele del of rs145204276 is associated with a remarkably lower incidence of cancer progression and metastasis.

Sign in / Sign up

Export Citation Format

Share Document